XBRANE BIOPHARMA AB earnings per share and revenue

Company revenue for the same period amounts to 65.80 M SEK despite the estimated figure of 145.00 M SEK. Estimated earnings per share for the next quarter are -0.03 SEK, and revenue is expected to reach 50.60 M SEK. Also watch annual changes over time to get a bigger picture of XBRANE earnings per share and revenue dynamics.